Randomized controlled trials conducted among adults with ASCVD have shown lipid-lowering medications including statins, ezetimibe, and PCSK9 inhibitors to prevent recurrent ASCVD events [15], [16], [17], [18], [19], [20], [21]. The gene discussed is PCSK9; the disease is atherosclerosis.